Allogeneic Transplant Outcomes in Adults Aged ≥75 Receiving Fludarabine/Melphalan Conditioning and Post-Transplant Cyclophosphamide

Key Points

• Transplant outcomes are improved with the use of fludarabine and melphalan conditioning in older adults.
• Key evidence reveals the effectiveness of cyclophosphamide as a post-transplant intervention.
• Assessment using allogeneic transplant outcomes highlights the feasibility in a previously underrepresented age group.
• Adverse effects may occur, indicating the need for careful monitoring in elderly patients.